Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.54 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.54 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.54 |
| ▸ | BACE1 | P56817 | 14/20 | 0.51 |
| ▸ | CTSD | P07339 | 4/20 | 0.51 |
| ▸ | GRM8 | O00222 | 1/20 | 0.44 |
| ▸ | GRM6 | O15303 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.44 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9544381 | 1.00 | DPP4 (0.54) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL29777789 | 1.00 | DPP4 (0.54) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL30463268 | 0.97 | DPP4 (0.56) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL29517333 | 0.97 | DPP4 (0.56) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL9293719 | 0.96 | BACE1 (0.51) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL9293727 | 0.96 | BACE1 (0.51) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL29777835 | 0.95 | BACE1 (0.53) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL30479086 | 0.95 | BACE1 (0.53) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL29777826 | 0.95 | BACE1 (0.53) | DPP4DPP8DPP9BACE1CTSD | |
| SCHEMBL30799949 | 0.93 | BACE1 (0.48) | DPP4DPP8DPP9BACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034090-A1 | CANNABINOID PRODRUG COMPOUNDS | FIRSTLIGHT PHARMACEUTICALS LLC (US) | 2026-02-05 | — | — | US | claimed |
| US-20250263437-A1 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) | 2025-08-21 | — | — | US | claimed |
| CN-117209592-A | Humanized type I collagen and preparation method and application thereof | 浙江大学 | 2023-12-12 | — | — | CN | claimed |
| EP-4276105-A1 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) | 2023-11-15 | — | — | EP | claimed |
| CN-116854807-A | Recombinant human VII type collagen and preparation method and application thereof | 浙江大学 | 2023-10-10 | — | — | CN | claimed |
| CN-116854808-A | Humanized III type collagen and preparation method thereof | 浙江大学 | 2023-10-10 | — | — | CN | claimed |
| CN-115369103-A | Construction of high specific activity keratinase mutant and pichia pastoris expression plasmid, and strain screening and purifying method | 河南合智医药科技有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-115011583-A | High-expression high-specific-activity proteinase K mutant sequence, construction of pichia pastoris expression plasmid, and strain screening and purifying method | 河南合智医药科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-114805489-A | Polypeptide for repairing skin injury or mucous membrane injury and application thereof | 四川好医生攀西药业有限责任公司 | 2022-07-29 | — | — | CN | claimed |
| WO-2022148289-A1 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | 四川好医生攀西药业有限责任公司 | 2022-07-14 | — | — | WO | claimed |
| US-20260139005-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | DONALD DANFORTH PLANT SCIENCE CENTER (US) | 2026-05-21 | — | — | US | disclosed |
| US-12629446-B2 | Vascular embolic system | 3-D MATRIX, LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12604903-B2 | Antimicrobial NCR peptides | DONALD DANFORTH PLANT SCIENCE CENTER | 2026-04-21 | — | — | US | disclosed |
| US-12606600-B2 | Antimicrobial NCR2 peptides | DONALD DANFORTH PLANT SCIENCE CENTER (US) | 2026-04-21 | — | — | US | disclosed |
| EP-4705479-A2 | ANTIMICROBIAL NODULE-SPECIFIC CYSTEINE-RICH PEPTIDE FOLDING VARIANTS | Donald Danforth Plant Science Center (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20220089661-A1 | ANTIMICROBIAL PEPTIDES | DONALD DANFORTH PLANT SCIENCE CENTER | 2022-03-24 | — | — | US | disclosed |
| US-20220081475-A1 | ANTIMICROBIAL PEPTIDES | DONALD DANFORTH PLANT SCIENCE CENTER | 2022-03-17 | — | — | US | disclosed |
| WO-1993009233-A2 | RECOMBINANT AMYLOID PRECURSOR PROTEIN INHIBITOR DOMAIN AND TREATMENT OF VARIOUS DISEASE STATES | THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES INC. (US) | 1993-05-13 | — | — | WO | disclosed |
| WO-1991005057-A1 | CD4 PRODUCTION IN PICHIA PASTORIS | THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES, INC. (US) | 1991-04-18 | — | — | WO | disclosed |
| EP-0206783-A2 | Expression and secretion of polypeptides from saccharomyces cerevisiae | The Salk Institute Biotechnology Industrial Associates, Inc. (US) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139005-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | ARG1, NOS2, VIP | DPP4 638/4885DPP8 1233/4885DPP9 586/4885 |
| US-12604903-B2 | Antimicrobial NCR peptides | CNBP, NRDC, RNGTT | DPP4 2202/4885DPP8 1577/4885DPP9 1788/4885 |
| US-20260034090-A1 | CANNABINOID PRODRUG COMPOUNDS | CNR1, CNR2, FAAH | DPP4 3074/4885DPP8 2553/4885DPP9 2976/4885 |
| US-12606600-B2 | Antimicrobial NCR2 peptides | UPF1, NRDC, SRRT | DPP4 3466/4885DPP8 3161/4885DPP9 3087/4885 |
| US-12629446-B2 | Vascular embolic system | TNNI3, MYLK, ADM2 | DPP4 3553/4885DPP8 4252/4885DPP9 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.